Synthetic Melanoma Peptides Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Synthetic Melanoma Peptides Vaccine, covering 2010-10-21 to 2018-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma [Phase 2]